✦ LIBER ✦

Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

✍ Scribed by Y. Rhee; M. Kang; Y. Min; D. Byun; Y. Chung; C. Ahn; K. Baek; J. Mok; D. Kim*; D. Kim**; H. Kim; Y. Kim; S. Myoung; D. Kim***; S.-K. Lim

Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 150 KB
Volume: 17
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-006-0200-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of alendronate and vitamin D3 on

Effect of alendronate and vitamin D3 on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women

✍ Sue A Shapses; David L Kendler; Richard Robson; Karen E Hansen; Robert M Sherrel 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Menopause and increasing age are associated with a decrease in calcium absorption that can contribute to the pathogenesis of osteoporosis. We hypothesized that alendronate plus vitamin D~3~ (ALN + D) would increase fractional calcium absorption (FCA). In this randomized, double‐blind, p

Effects of menatetrenone on the bone and

Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study

✍ Hajime Orimo; Masataka Shiraki; Akio Tomita; Hirotoshi Morii; Takuo Fujita; Masa 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 159 KB

Effect of daily oral minodronate on vert

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

✍ T. Matsumoto; H. Hagino; M. Shiraki; M. Fukunaga; T. Nakano; K. Takaoka; H. Mori 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

Multinational, Placebo-Controlled, Rando

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

✍ H. A. P. Pols; D. Felsenberg; D. A. Hanley; J. Štepán; M. Muñoz-Torres; T. J. Wi 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 86 KB

Two-year effects of alendronate on bone

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

✍ Jonathan D. Adachi; Kenneth G. Saag; Pierre D. Delmas; Uri A. Liberman; Ronald D 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

The effects of rasagiline on cognitive d

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

✍ Hasmet A. Hanagasi; Hakan Gurvit; Pınar Unsalan; Hilal Horozoglu; Nese Tuncer; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef